These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29750676)

  • 21. Alloantibody Responses After Renal Transplant Failure Can Be Better Predicted by Donor-Recipient HLA Amino Acid Sequence and Physicochemical Disparities Than Conventional HLA Matching.
    Kosmoliaptsis V; Mallon DH; Chen Y; Bolton EM; Bradley JA; Taylor CJ
    Am J Transplant; 2016 Jul; 16(7):2139-47. PubMed ID: 26755448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant.
    Tagliamacco A; Cioni M; Comoli P; Ramondetta M; Brambilla C; Trivelli A; Magnasco A; Biticchi R; Fontana I; Dulbecco P; Palombo D; Klersy C; Ghiggeri GM; Ginevri F; Cardillo M; Nocera A
    Transpl Int; 2014 Jul; 27(7):667-73. PubMed ID: 24629017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of HLA-DQ in kidney transplantation: time to reevaluate human leukocyte antigen-matching priorities to improve transplant outcomes? An expert review and recommendations.
    Tambur AR; Kosmoliaptsis V; Claas FHJ; Mannon RB; Nickerson P; Naesens M
    Kidney Int; 2021 Nov; 100(5):1012-1022. PubMed ID: 34246656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-DQ matching in cadaveric renal transplantation.
    Freedman BI; Thacker LR; Heise ER; Adams PL
    Clin Transplant; 1997 Oct; 11(5 Pt 2):480-4. PubMed ID: 9361945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation.
    Wozniak LJ; Hickey MJ; Venick RS; Vargas JH; Farmer DG; Busuttil RW; McDiarmid SV; Reed EF
    Transplantation; 2015 Jul; 99(7):1416-22. PubMed ID: 26038872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-DQ antibodies in alloimmunity, what makes them different?
    Meneghini M; Tambur AR
    Curr Opin Organ Transplant; 2023 Oct; 28(5):333-339. PubMed ID: 37219535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA.
    Jucaud V
    J Immunol Res; 2017; 2017():2748614. PubMed ID: 28331856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
    Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan KW; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):76-82. PubMed ID: 9267667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor-specific antibody detection: comparison of single antigen assay and Luminex crossmatches.
    Caro-Oleas JL; González-Escribano MF; Toro-Llamas S; Acevedo MJ; Martinez-Bravo MJ; Aguilera I; Núñez-Roldán A
    Tissue Antigens; 2010 Nov; 76(5):398-403. PubMed ID: 20630037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of ischemic lesions in the donor kidney, donor age, recipient age and HLA (A, B, C, DR, DQ) matching on clinical course after kidney grafting.
    Christiaans MH; Peltenburg HG; Niemann FH; Kootstra G; Lavrijssen AT; van den Berg-Loonen PM; Tiebosch A; Leunissen KM; van Hooff JP
    Transpl Int; 1992; 5 Suppl 1():S627-8. PubMed ID: 14621893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Humoral immune reactivity against human leukocyte antigen (HLA)-DQ graft molecules in the early posttransplantation period.
    Iniotaki-Theodoraki AG; Boletis JN; Trigas GCh; Kalogeropoulou HG; Kostakis AG; Stavropoulos-Giokas CG
    Transplantation; 2003 May; 75(9):1601-3. PubMed ID: 12792524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lights and shadows of anti-HLA antibodies detected by solid-phase assay.
    Picascia A; Sabia C; Grimaldi V; Montesano ML; Sommese L; Schiano C; Napoli C
    Immunol Lett; 2014 Nov; 162(1 Pt A):181-7. PubMed ID: 25171913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of HLA matching, donor/recipient sex, and incidence of acute rejection on survival in cardiac allograft recipients receiving cyclosporin A and azathioprine.
    Khaghani A; Yacoub M; McCloskey D; Awad J; Burden M; Fitzgerald M; Hawes R; Holmes J; Smith J; Banner N
    Transplant Proc; 1989 Feb; 21(1 Pt 1):799-800. PubMed ID: 2650273
    [No Abstract]   [Full Text] [Related]  

  • 34. Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation.
    Meneghini M; Crespo E; Niemann M; Torija A; Lloberas N; Pernin V; Fontova P; Melilli E; Favà A; Montero N; Manonelles A; Cruzado JM; Palou E; Martorell J; Grinyó JM; Bestard O
    Front Immunol; 2020; 11():623276. PubMed ID: 33776988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-DQ alloantibodies directly activate the endothelium and compromise differentiation of FoxP3
    Cross AR; Lion J; Poussin K; Assayag M; Taupin JL; Glotz D; Mooney N
    Kidney Int; 2019 Sep; 96(3):689-698. PubMed ID: 31307777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel aspects of epitope matching and practical application in kidney transplantation.
    Lim WH; Wong G; Heidt S; Claas FHJ
    Kidney Int; 2018 Feb; 93(2):314-324. PubMed ID: 29061333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human leukocyte antigen class II DQ alpha and beta epitopes identified from sera of kidney allograft recipients.
    Deng CT; El-Awar N; Ozawa M; Cai J; Lachmann N; Terasaki PI
    Transplantation; 2008 Aug; 86(3):452-9. PubMed ID: 18698250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after heart transplantation.
    Omrani O; Alawwami M; Buraiki J; Selimovic N
    Ann Saudi Med; 2018; 38(2):97-104. PubMed ID: 29620542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical evaluation of a possible role of HLA epitope matching in kidney transplantation.
    Kumru Sahin G; Unterrainer C; Süsal C
    Transplant Rev (Orlando); 2020 Apr; 34(2):100533. PubMed ID: 32007300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rises and falls in donor-specific and third-party HLA antibody levels after antibody incompatible transplantation.
    Higgins R; Lowe D; Hathaway M; Lam F; Kashi H; Tan LC; Imray C; Fletcher S; Chen K; Krishnan N; Hamer R; Zehnder D; Briggs D
    Transplantation; 2009 Mar; 87(6):882-8. PubMed ID: 19300192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.